Executive Committee: MedinCell S.A.

Manager
Positions heldSince
Christophe Douat

Christophe Douat

61 year

Chief Executive Officer 2003-01-08
Founder 2003-01-08
Stéphane Postic

Stéphane Postic

51 year

Director of Finance/CFO 2023-08-31
Grace Kim

Grace Kim

Investor Relations Contact -
Julie Alimi

Julie Alimi

General Counsel -
Richard Malamut

Richard Malamut

65 year

Chief Tech/Sci/R&D Officer 2022-05-08
Adolfo Lopez-Noriega

Adolfo Lopez-Noriega

Chief Tech/Sci/R&D Officer 2016-12-31
Franck Pouzache

Franck Pouzache

Human Resources Officer 2020-03-31
Sébastien Magnat

Sébastien Magnat

Chief Operating Officer 2019-03-31
Christophe Roberge

Christophe Roberge

Chief Tech/Sci/R&D Officer 2016-04-30

Composition of the Board of Directors: MedinCell S.A.

Director
CommitteesSince
Philippe Guy

Philippe Guy

Chairman 2024-03-12
Virginie Lleu

Virginie Lleu

Compensation Committee Chair 2016-05-24
Tone Kvåle

Tone Kvåle

56 year

Audit Committee Chair 2022-06-12
Sabri Markabi

Sabri Markabi

Director/Board Member 2024-03-12
Independent Dir/Board Member 2017-07-04
Elisabeth Kogan

Elisabeth Kogan

Director/Board Member 2020-12-14

Former Officers and Directors: MedinCell S.A.

Insider
Positions held
SinceUntil
Anh Nguyen
Anh Nguyen
Chairman 2014-07-21 2024-02-14
Founder 2003-01-08 2024-02-14
Joël Richard
Joël Richard
Chief Tech/Sci/R&D Officer 2022-04-30 2023-01-31
Nicolas Heuzé
Nicolas Heuzé
Corporate Officer/Principal 2012-12-31 2020-09-30
Stéphane Lucchini
Stéphane Lucchini
Corporate Officer/Principal 2009-12-31 2018-12-31
Rachel Almeras
Rachel Almeras
Director/Board Member 2018-02-11 -
Karine Lignel
Karine Lignel
Director/Board Member 2017-11-05 -
Jaime Arango
Jaime Arango
Director of Finance/CFO 2017-07-31 -
Nadia Black
Nadia Black
Human Resources Officer 2014-12-31 -
Georges Gaudriault
Georges Gaudriault
Chief Tech/Sci/R&D Officer - -
Franck Sturtz
Franck Sturtz
Director/Board Member - -
Mélanie Julien
Mélanie Julien
Chief Operating Officer - -

Age distribution of managers

Parity Men Women

Male 14
Female 4

Of which Executive Committee

Male 8
Female 1

Of which Directors

Male 2
Female 3
ESG MSCI
-
Logo MedinCell S.A.
MedinCell S.A. is a pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas, combining its proprietary BEPO® technology with active ingredients already known and marketed. The BEPO® technology allows the regular delivery of a drug at optimal therapeutic dose for several days, weeks or months from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. The first treatment based on BEPO® technology, intended for the treatment of schizophrenia, was approved by the FDA in April 2023, and is now distributed in the United States by Teva under the name UZEDY® (BEPO® technology is licensed to Teva under the name SteadyTeqTM). As of March 31, 2024, the company had a portfolio of 2 products in phase III clinical development and 2 products in preclinical development.
Employees
131
Calendar
More about the company

Departures of Key Persons